BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Plexxikon Inc. 

91 Bolivar Drive

Berkeley  California  94710  U.S.A.
Phone: 510-647-4000 Fax: 510-548-8014


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Start Up





 Company News
Plexxikon Inc. And Quantumleap Healthcare Collaborative Announce Selection Of PLX3397 For I-SPY 2 TRIAL In Breast Cancer 12/11/2014 8:00:33 AM
OncoSec Medical Inc. And Plexxikon Inc. Collaborate To Explore Combination Immunotherapy In Preclinical Tumor Studies 11/18/2014 12:35:42 PM
Plexxikon Inc. Announces Promising Preliminary PLX3397 Phase 1 Extension Data In Patients With Pigmented Villonodular Synovitis (PVNS) 5/15/2014 9:58:15 AM
Plexxikon Inc. Announces PLX3397 Data Presentations At American Society of Clinical Oncology 2014 Annual Meeting 5/15/2014 8:05:23 AM
Plexxikon Inc. Taps New CEO, COO 5/31/2013 8:43:22 AM
Plexxikon Inc. Announces Three-Year Survival in Zelboraf-Treated Metastatic Melanoma Patients 11/9/2012 9:57:57 AM
Plexxikon Inc. Announces European Approval of Zelboraf® for the Treatment of Patients With BRAF Mutation-Positive Metastatic Melanoma 2/21/2012 6:49:47 AM
Plexxikon Inc. Advances Novel Targeted Treatment PLX3397 in Blood Cancer 12/13/2011 6:53:20 AM
Plexxikon Inc. Advances Novel Targeted Treatment PLX3397 in Blood Cancer 12/12/2011 12:17:21 PM
Plexxikon Inc. Novel Agents Aim to Address Cancer Treatment in New Ways 11/14/2011 9:49:40 AM
123456